Published June 2021 | Version v1
Journal article

How do patient-reported outcomes compare with clinician assessments? A prospective study of radiation dermatitis in breast cancer

  • 1. Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto (Canada)
  • 2. MacroStat Inc., Toronto (Canada)

Description

Highlights: • Patient- and clinician-reported outcomes consistently demonstrated low agreement. • Clinicians significantly underreported all symptoms in relation to patients. • Use of patient-reported outcomes in routine practice may improve symptom management. • A new tool is needed to score symptoms from the patient and clinician perspectives. Breast cancer patients frequently develop radiation dermatitis (RD) when undergoing post-operative radiation therapy (RT). Traditional RD assessment methods measure clinician-reported outcomes (CROs), but patient-reported outcomes (PROs) have gained recent popularity. The purpose of this prospective analysis was to compare PROs with CROs of breast RD.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radonc.2021.03.020

Additional details

Identifiers

DOI
10.1016/j.radonc.2021.03.020;
PII
S0167814021061466;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
159
Journal Page Range
p. 98-105
ISSN
0167-8140
CODEN
RAONDT

INIS

Country of Publication
Netherlands
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
54013818
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
DERMATITIS; MAMMARY GLANDS; NEOPLASMS; PATIENTS; RADIOTHERAPY; SYMPTOMS
Descriptors DEC
BODY; DISEASES; GLANDS; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; SKIN DISEASES; THERAPY

Optional Information

Copyright
Copyright (c) 2021 Elsevier B.V. All rights reserved.